Mori M - Search Results

1

Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.

Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M, Mori M. Kosaka Y, et al. Among authors: mori m. Int J Oncol. 2007 Aug;31(2):333-8. Int J Oncol. 2007. PMID: 17611689

2

Analysis of the gene-expression profile regarding the progression of human gastric carcinoma.

Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K. Mori M, et al. Surgery. 2002 Jan;131(1 Suppl):S39-47. doi: 10.1067/msy.2002.119292. Surgery. 2002. PMID: 11821786

3

Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M. Mimori K, et al. Among authors: mori m. Oncology. 2002;62(4):327-32. doi: 10.1159/000065064. Oncology. 2002. PMID: 12138240

4

Clinical significance of the expression of activin A in esophageal carcinoma.

Yoshinaga K, Mimori K, Yamashita K, Utsunomiya T, Inoue H, Mori M. Yoshinaga K, et al. Among authors: mori m. Int J Oncol. 2003 Jan;22(1):75-80. Int J Oncol. 2003. PMID: 12469187

5

Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus.

Mimori K, Inoue H, Shiraishi T, Matsuyama A, Mafune K, Tanaka Y, Mori M. Mimori K, et al. Among authors: mori m. Oncology. 2003;64(3):275-9. doi: 10.1159/000069317. Oncology. 2003. PMID: 12697969

6

Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility.

Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori M. Yoshinaga K, et al. Among authors: mori m. Ann Surg Oncol. 2003 Jun;10(5):582-7. doi: 10.1245/aso.2003.08.020. Ann Surg Oncol. 2003. PMID: 12794027

7

Stimulation of CD40 inhibits Fas- or chemotherapy-mediated apoptosis and increases cell motility in human gastric carcinoma cells.

Yamaguchi H, Tanaka F, Sadanaga N, Ohta M, Inoue H, Mori M. Yamaguchi H, et al. Among authors: mori m. Int J Oncol. 2003 Dec;23(6):1697-702. Int J Oncol. 2003. PMID: 14612943

8

Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.

Mimori K, Ueo H, Kuroki T, Shiraishi T, Creer S, Taylor S, Ishii H, Mori M. Mimori K, et al. Among authors: mori m. Oncol Rep. 2004 Jul;12(1):19-23. Oncol Rep. 2004. PMID: 15201953

9

Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.

Utsunomiya T, Inoue H, Tanaka F, Yamaguchi H, Ohta M, Okamoto M, Mimori K, Mori M. Utsunomiya T, et al. Among authors: mori m. Ann Surg Oncol. 2004 Oct;11(10):934-40. doi: 10.1245/ASO.2004.01.029. Ann Surg Oncol. 2004. PMID: 15466353

10

The high expression of Fractalkine results in a better prognosis for colorectal cancer patients.

Ohta M, Tanaka F, Yamaguchi H, Sadanaga N, Inoue H, Mori M. Ohta M, et al. Among authors: mori m. Int J Oncol. 2005 Jan;26(1):41-7. Int J Oncol. 2005. PMID: 15586223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,983 results

Search Page

Filters